Zdrowie i gospodarka · 05/06/2013

FDA Requests Public Comment on Proposed Collection of Biological Product and Human Cell Reporting Information

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to the reporting of biological product and human cell deviations in manufacturing, as well as deviations in human cells, tissues, and cellular and tissue-based products, through the use of Forms FDA 3486 and 3486A.